Movement Alert｜DUALITYBIO-B falls 5.14% in Regular Trading, buyback support overshadowed by STAR Market fundraising scrutiny

Market Focus10-15

On October 15, DUALITYBIO-B fell 5.14% in Regular Trading, trading at HK$157.0, with turnover of HK$94.99 million.

The latest publicly available catalyst points to continued pressure from the company’s planned STAR Market IPO and related fundraising scrutiny, which appears to be outweighing support from its latest share buyback.

Background shows the company disclosed on October 14 that it repurchased 21,000 shares at HK$164.20 to HK$167.00 per share for about HK$3.48 million, with the shares to be held in treasury. However, market focus has shifted to its proposed roughly RMB4.1 billion STAR Market fundraising, despite cash of about RMB3.006 billion as of June 30. The company also reported first-half revenue of RMB219 million, adjusted net loss of RMB627 million, operating cash outflow of RMB424 million, while recent option exercises added new shares, limiting the buyback’s sentiment support.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment